뒤로
Adcock Ingram Holdings Ltd(AIHLF) 가격
AIHLF 주가 차트
AIHLF 수입
Adcock Ingram Holdings Ltd
$3.5
0%
$0
종가: Feb 10, 16:00:00 GMT-5
$3.5
0%
$0
애프터마켓: Feb 10, 16:57:19 GMT-5
Earnings FAQ
AIHLF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Adcock Ingram Holdings Ltd AIHLF의 지난 분기 매출 실적은 어땠나요?
Adcock Ingram Holdings Ltd의 매출 추정치는 얼마인가요?
Adcock Ingram Holdings Ltd의 수익 품질 점수는 얼마인가요?
Adcock Ingram Holdings Ltd는 언제 수익을 보고하나요?
Adcock Ingram Holdings Ltd의 예상 수익은 얼마인가요?
Adcock Ingram Holdings Ltd은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$3.5
시가
$3.5
일일 범위
$3.5 - $3.5
52주 범위
$2.45 - $3.5
거래량
100
평균 거래량
0
EPS(TTM)
0.32
배당수익률
--
시가총액
$513.6M
AIHLF란 무엇인가요?
Adcock Ingram Holdings Ltd. is a pharmaceutical company, which engages in the manufacture, marketing, and distribution of healthcare products to both private and public sectors of the market. The company is headquartered in Midrand, Gauteng. The company went IPO on 2008-08-25. The firm manufactures, markets, and distributes a range of healthcare and consumer products, and is a supplier to the private sector. Its segments include Consumer, Over the Counter (OTC), Prescription, Hospital, and Other. The Consumer segment is engaged mainly in the fast-moving consumer goods (FMCG) space. The OTC segment focuses on brands sold predominantly in pharmacies. The Prescription segment markets products prescribed by medical practitioners, and specialized instruments and surgical products. Its Hospital segment supplies hospital and critical care products, including intravenous solutions, blood collection products, and renal dialysis systems. The Other segment includes shared services and other support services, including regulatory services in India, as well as the investment in the joint venture and cash and bank overdraft balances, which are managed on a central basis in Southern Africa.